Muscle

  • 3E023 - Percutaneous
    • 3E0230
      • 3E02305 - Introduction Muscle to Other Antineoplastic with Antineoplastic, Percutaneous Approach
      • 3E0230M - Introduction Muscle to Monoclonal Antibody with Antineoplastic, Percutaneous Approach
    • 3E0232
      • 3E02328 - Introduction Muscle to Oxazolidinones with Anti-infective, Percutaneous Approach
      • 3E02329 - Introduction Muscle to Other Anti-infective with Anti-infective, Percutaneous Approach
    • 3E0233
      • 3E0233Z - Introduction Muscle to No Qualifier with Anti-inflammatory, Percutaneous Approach
    • 3E0234
      • 3E02340 - Introduction Muscle to Influenza Vaccine with Serum, Toxoid and Vaccine, Percutaneous Approach
      • 3E0234Z - Introduction Muscle to No Qualifier with Serum, Toxoid and Vaccine, Percutaneous Approach
    • 3E0236
      • 3E0236Z - Introduction Muscle to No Qualifier with Nutritional Substance, Percutaneous Approach
    • 3E0237
      • 3E0237Z - Introduction Muscle to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach
    • 3E023B
      • 3E023BZ - Introduction Muscle to No Qualifier with Anesthetic Agent, Percutaneous Approach
    • 3E023G
      • 3E023GC - Introduction Muscle to Other Substance with Other Therapeutic Substance, Percutaneous Approach
    • 3E023H
      • 3E023HZ - Introduction Muscle to No Qualifier with Radioactive Substance, Percutaneous Approach
    • 3E023K
      • 3E023KZ - Introduction Muscle to No Qualifier with Other Diagnostic Substance, Percutaneous Approach
    • 3E023N
      • 3E023NZ - Introduction Muscle to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach
    • 3E023T
      • 3E023TZ - Introduction Muscle to No Qualifier with Destructive Agent, Percutaneous Approach